"","title","geo_accession","status","submission_date","last_update_date","type","channel_count","source_name_ch1","organism_ch1","characteristics_ch1","characteristics_ch1.1","characteristics_ch1.2","growth_protocol_ch1","molecule_ch1","extract_protocol_ch1","label_ch1","label_protocol_ch1","taxid_ch1","hyb_protocol","scan_protocol","description","data_processing","platform_id","contact_name","contact_email","contact_laboratory","contact_department","contact_institute","contact_address","contact_city","contact_zip/postal_code","contact_country","supplementary_file","data_row_count","cell line:ch1","disease status:ch1","source of rna:ch1"
"GSM1590969","PNT2-exosome","GSM1590969","Public on Jan 23 2018","Jan 23 2015","Jan 23 2018","RNA","1","exosome from PNT2_normal_cells","Homo sapiens","source of rna: exosome","cell line: PNT2","disease status: normal","Cultured in RPMI containing 10% heat-inactivated FBS and an antibiotic-antimycotic.","total RNA","Isolation of exosomal RNA and cellular RNAs was performed using the miRNeasy Mini Kit according to the manufacture instruction.","Cy3","100 ng of each RNA sample was labeled with the miRNA Complete Labeling Reagent and Hybridization kit (Agilent Technologies) according to the manufacturer鈥檚 instructions.","9606","Labeled RNA was hybridized to the Human miRNA Microarray 3.0 8x15K (G4470C Agilent Technologies) with the miRNA Complete Labeling Reagent and Hybridization kit (Agilent Technologies) according to the manufacturer鈥檚 instructions.","Microarray slides were scanned in an Agilent Technologies G2505C Microarray Scanner at 5 micron resolution.","Exosomal total RNA from PNT2 cells","Images were quantified using Agilent Feature Extraction software version 10.7.3.1 (Agilent) using default parameters (Grid: 021827_D_20081121) to obtain background subtracted and spatially detrended Processed Signal intensities. Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.","GPL14767","Nobuyoshi,,Kosaka","hanta73@gmail.com","Division of Molecular and Cellular Medicine","Research of Molecular Functions and Targets","National Cancer Center","5-1-1, Tsukiji, Chuo-ku","Tokyo","104-0045","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1590nnn/GSM1590969/suppl/GSM1590969_PNT2-Exo.txt.gz","15739","PNT2","normal","exosome"
"GSM1590970","PC3M-exosome","GSM1590970","Public on Jan 23 2018","Jan 23 2015","Jan 23 2018","RNA","1","exosome from PC3M_cancer_cells","Homo sapiens","source of rna: exosome","cell line: PC3M","disease status: cancer","Cultured in RPMI containing 10% heat-inactivated FBS and an antibiotic-antimycotic.","total RNA","Isolation of exosomal RNA and cellular RNAs was performed using the miRNeasy Mini Kit according to the manufacture instruction.","Cy3","100 ng of each RNA sample was labeled with the miRNA Complete Labeling Reagent and Hybridization kit (Agilent Technologies) according to the manufacturer鈥檚 instructions.","9606","Labeled RNA was hybridized to the Human miRNA Microarray 3.0 8x15K (G4470C Agilent Technologies) with the miRNA Complete Labeling Reagent and Hybridization kit (Agilent Technologies) according to the manufacturer鈥檚 instructions.","Microarray slides were scanned in an Agilent Technologies G2505C Microarray Scanner at 5 micron resolution.","Exosomal total RNA from PC3M cells","Images were quantified using Agilent Feature Extraction software version 10.7.3.1 (Agilent) using default parameters (Grid: 021827_D_20081121) to obtain background subtracted and spatially detrended Processed Signal intensities. Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.","GPL14767","Nobuyoshi,,Kosaka","hanta73@gmail.com","Division of Molecular and Cellular Medicine","Research of Molecular Functions and Targets","National Cancer Center","5-1-1, Tsukiji, Chuo-ku","Tokyo","104-0045","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1590nnn/GSM1590970/suppl/GSM1590970_PC3M-Exo.txt.gz","15739","PC3M","cancer","exosome"
"GSM1590971","PNT2-cellular","GSM1590971","Public on Jan 23 2018","Jan 23 2015","Jan 23 2018","RNA","1","PNT2 cells_normal_cells","Homo sapiens","source of rna: cellular","cell line: PNT2","disease status: normal","Cultured in RPMI containing 10% heat-inactivated FBS and an antibiotic-antimycotic.","total RNA","Isolation of exosomal RNA and cellular RNAs was performed using the miRNeasy Mini Kit according to the manufacture instruction.","Cy3","100 ng of each RNA sample was labeled with the miRNA Complete Labeling Reagent and Hybridization kit (Agilent Technologies) according to the manufacturer鈥檚 instructions.","9606","Labeled RNA was hybridized to the Human miRNA Microarray 3.0 8x15K (G4470C Agilent Technologies) with the miRNA Complete Labeling Reagent and Hybridization kit (Agilent Technologies) according to the manufacturer鈥檚 instructions.","Microarray slides were scanned in an Agilent Technologies G2505C Microarray Scanner at 5 micron resolution.","Cellular total RNA from PNT2 cells.","Images were quantified using Agilent Feature Extraction software version 10.7.3.1 (Agilent) using default parameters (Grid: 021827_D_20081121) to obtain background subtracted and spatially detrended Processed Signal intensities. Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.","GPL14767","Nobuyoshi,,Kosaka","hanta73@gmail.com","Division of Molecular and Cellular Medicine","Research of Molecular Functions and Targets","National Cancer Center","5-1-1, Tsukiji, Chuo-ku","Tokyo","104-0045","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1590nnn/GSM1590971/suppl/GSM1590971_PNT2-Cell.txt.gz","15739","PNT2","normal","cellular"
"GSM1590972","PC3M-cellular","GSM1590972","Public on Jan 23 2018","Jan 23 2015","Jan 23 2018","RNA","1","PC3M cells_cancer_cells","Homo sapiens","source of rna: cellular","cell line: PC3M","disease status: cancer","Cultured in RPMI containing 10% heat-inactivated FBS and an antibiotic-antimycotic.","total RNA","Isolation of exosomal RNA and cellular RNAs was performed using the miRNeasy Mini Kit according to the manufacture instruction.","Cy3","100 ng of each RNA sample was labeled with the miRNA Complete Labeling Reagent and Hybridization kit (Agilent Technologies) according to the manufacturer鈥檚 instructions.","9606","Labeled RNA was hybridized to the Human miRNA Microarray 3.0 8x15K (G4470C Agilent Technologies) with the miRNA Complete Labeling Reagent and Hybridization kit (Agilent Technologies) according to the manufacturer鈥檚 instructions.","Microarray slides were scanned in an Agilent Technologies G2505C Microarray Scanner at 5 micron resolution.","Cellular total RNA from PC3M cells.","Images were quantified using Agilent Feature Extraction software version 10.7.3.1 (Agilent) using default parameters (Grid: 021827_D_20081121) to obtain background subtracted and spatially detrended Processed Signal intensities. Features flagged in Feature Extraction as Feature Non-uniform outliers were excluded.","GPL14767","Nobuyoshi,,Kosaka","hanta73@gmail.com","Division of Molecular and Cellular Medicine","Research of Molecular Functions and Targets","National Cancer Center","5-1-1, Tsukiji, Chuo-ku","Tokyo","104-0045","Japan","ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1590nnn/GSM1590972/suppl/GSM1590972_PC3M-Cell.txt.gz","15739","PC3M","cancer","cellular"
